Koye Endeavours Private Limited
About Koye Endeavours Private Limited
Data last updated:
Koye Endeavours Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 June 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2022PTC385683. Its GSTIN is 27AAJCK6297K1ZR (Maharashtra).
The company has an authorised share capital of ₹9.5 Cr and a paid-up capital of ₹6.8 Cr. It is led by directors Ravindra Yogesh Shenoy and Preetish Mohan Toraskar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 504 Autumn Grove Building Akurli Road Lokhandwala Township Kandivali (East), Mumbai, Maharashtra, India – 400101.
As per the financials filed for FY 2025, the company reported a revenue of ₹95,450, a growth of 99% compared to the previous year. For the same year it recorded a net profit of ₹53,060 (net margin 55.6%) and EBITDA of ₹70,520 (EBITDA margin 73.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Koye Endeavours Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address504 Autumn Grove Building Akurli Road Lokhandwala Township Kandivali (East), Mumbai, Maharashtra, India – 400101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Koye Endeavours Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Koye Endeavours Private Limited
FY 2025 filings availableKoye Endeavours Private Limited reported revenue of ₹95,450 (up 99% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 99% in the latest year. EBITDA rose 166% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹70,520 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹53,060 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 73.9% | ||
| Net Profit Margin | 55.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Koye Endeavours Private Limited, buy the company report.
Board of directors of Koye Endeavours Private Limited
Koye Endeavours has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravindra Yogesh Shenoy | Director | 29 Jun 2022 | 4 Years 4 Months | Current |
| Preetish Mohan Toraskar Also directs: Koye Enterprises LLP, Blue Oyster Enterprises LLP, Koye Pharmaceuticals Private Limited and 3 more | Director | 29 Jun 2022 | 4 Years 4 Months | Current |
Peer comparison
Koye Endeavours Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shree Pharmaceuticals Private Limited | ₹97,345 (FY 2017) | -33.0% | Navi Mumbai, Maharashtra, India | |||
| Jayvisto Formulations Private Limited | ₹97,204 (FY 2024) | 525.0% | Patna, Bihar, India | |||
| Retec Formulations Private Limited | ₹96,531 (FY 2025) | New Delhil, Delhi, India | ||||
| Oxeeco Meditek Private Limited | ₹96,499 (FY 2024) | 34.0% | Sanathnagar, Hyderabad, Telangana, India | |||
| Prakash Mother and Child Hospital Private Limited | ₹95,506 (FY 2025) | -89.0% | Jaipur, Rajasthan, India | |||
| Koye Endeavours Private Limitedthis company | ₹95,450 (FY 2025) | ₹53,060 | 55.6% | 99.0% | Mumbai, Maharashtra, India | |
| Lorda Pharmaceuticals Private Limited | ₹94,569 (FY 2016) | -33.0% | Mumbai, Maharashtra, India | |||
| Excel Healthcare Private Limited | ₹94,529 (FY 2018) | Mehsana, Gujarat, India | ||||
| Bezel Pharma Pvt Ltd | ₹93,706 (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Gencor Cultech India Private Limited | ₹92,572 (FY 2021) | Chennai, Tamil Nadu, India | ||||
| Associated Auxichem Private Limited | ₹91,626 (FY 2025) | Mumbai, Maharashtra, India |
To see the full peer comparison of Koye Endeavours Private Limited, buy the company report.
Auditor
Koye Endeavours Private Limited is audited by K Halwai and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K Halwai and Associates | FY 2023 | 0155039W |
Shareholding
The shareholding of Koye Endeavours Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Koye Endeavours Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Koye Endeavours Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Koye Endeavours Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Koye Endeavours Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
GST
Koye Endeavours has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCK6297K1ZR | Maharashtra | Active | 04 Jul 2023 |
To see the full GST registrations and return filing status of Koye Endeavours Private Limited, buy the company report.
Recent activity
Koye Endeavours Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Preetish Mohan Toraskar was appointed as Director on 29 Jun 2022.
Frequently asked questions
Koye Endeavours is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 June 2022 (4+ years old) and is registered under CIN U24100MH2022PTC385683.
Koye Endeavours has 2 current directors:
- Ravindra Yogesh Shenoy - Director
- Preetish Mohan Toraskar - Director
The latest financial statements of Koye Endeavours on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Koye Endeavours is 27AAJCK6297K1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Koye Endeavours is U24100MH2022PTC385683. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Koye Endeavours was incorporated on 29 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Koye Endeavours by revenue are Shree Pharmaceuticals Private Limited, Jayvisto Formulations Private Limited, Retec Formulations Private Limited, Oxeeco Meditek Private Limited, Prakash Mother and Child Hospital Private Limited and 5 more, all in the Pharma industry (Formulations).
Preetish Mohan Toraskar was appointed as Director on 29 Jun 2022. Ravindra Yogesh Shenoy was appointed as Director on 29 Jun 2022.
The registered office of Koye Endeavours is at 504 Autumn Grove Building Akurli Road Lokhandwala Township Kandivali East, Mumbai, Maharashtra, India – 400101.
Koye Endeavours operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Koye Endeavours is compliant as of 01 August 2026. The company is actively filing with the Registrar of Companies.